Method of determining susceptibility to bipolar disorders
CA 2390670 C · Owner: Centre For Addiction And Mental Health · Inventors: Muglia, Pierandrea; Kennedy, James L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods and kits for determining susceptibility of a patient to bipolar disorders are described. The method comprises the steps of : (a) obtaining a sample from a patient; and (b) testing the sample for the presence of a polymorphism selected from (i) a 2 repeat allele in the variable number of tandem repeat (VNTR) region of the DRD4 gene and (ii) a 4 repeat allele in the VNTR region of the DRD4 gene wherein the presence of the 2 repeat allele indicates that the patient is less susceptible to a bipolar disorder and the presence of the 4 repeat allele indicates that the patient is more susceptible to a bipolar disorder.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 14, 2002 and granted August 5, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 14, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 14, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.